Pharmaceutical Filtration Consumables Market by Type (Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies), Technique (Ultrafiltration), Sterility Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030

icon1
USD 18.03 BN
MARKET SIZE, 2030
icon2
CAGR 8.5%
(2025-2030)
icon3
319
REPORT PAGES
icon4
408
MARKET TABLES

OVERVIEW

pharmaceutical-filtration-consumables-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The pharmaceutical filtration consumables market is projected to reach USD 18.03 billion by 2030 from USD 11.96 billion in 2025, at a CAGR of 8.5% from 2025 to 2030. Pharmaceutical filtration is a process wherein solid and semi-solid particles present in a suspension are separated from a liquid or gas by employing membrane filters, such as filter sheets, cartridges & capsules, papers, depth filters, and others. Growth in this market is fueled by technological innovations and the emergence of advanced membrane/filter designs.

KEY TAKEAWAYS

  • BY REGION
    By region, the Asia Pacific pharmaceutical filtration consumables market is expected to be the fastest-growing segment, at a CAGR of 10.6% during the forecast period.
  • BY PRODUCT
    By product, the filters segment is projected to grow at the fastest rate of 9.2% from 2025 to 2030.
  • BY TECHNIQUE
    By technique, the microfiltration segment is projected to grow at the fastest rate from 2025 to 2030.
  • BY STERILITY TYPE
    By sterility type, sterile preparations dominate the pharmaceutical filtration consumables market.
  • BY APPLICATION
    By application, the final product processing segment is expected to dominate the market.
  • BY END USER
    By end user, the pharmaceutical & biopharmaceutical companies segment is expected to dominate the market.
  • COMPETITIVE LANDSCAPE
    Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany) were identified as the star players in the pharmaceutical filtration consumables market, given their strong market share and product footprint.
  • COMPETITIVE LANDSCAPE
    Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), and Graver Technologies, LLC (US) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging ma

The pharmaceutical filtration consumables market is expanding rapidly, driven by factors such as the shift toward single-use technologies (SUTs) and disposables and advancements in membrane filter designs.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The pharmaceutical filtration consumables market undergoes rapid changes in response to shifts in manufacturing, regulatory, and therapeutic trends. The increasing commercialization of biologics, biosimilars, and advanced modalities such as mRNA vaccines and cell & gene therapies is resulting in sharply increasing demands for high-performance consumables, including depth filters, membrane filters, virus-retentive cartridges, and sterile single-use assemblies. As large-scale production lines grow in size and evolve into multi-product, flexible facilities, manufacturers increasingly turn to ready-to-use, pre-validated filtration consumables that provide sterility, consistency, and operational efficiency across upstream, downstream, and final fill. The growing adoption of single-use and hybrid bioprocessing platforms is driving the demand for sterile capsules, integrated fluid paths, and contamination-controlled consumables that meet FDA, EMA, and international GMP standards. Recently, CDMOs and biomanufacturers have increasingly relied on effective sterilizing-grade filters and high-capacity filter media. These tools help support higher batch throughput while minimizing downtime and ensuring strong product quality.

pharmaceutical-filtration-consumables-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Technological innovations & advanced membrane/filter designs
  • Shift toward single-use technologies (SUTs) and disposables
RESTRAINTS
Impact
Level
  • High cost of advanced filtration consumables and technologies
OPPORTUNITIES
Impact
Level
  • Adoption of automation, digitalization, and smart filtration workflows
CHALLENGES
Impact
Level
  • Membrane fouling and unpredictability with complex biologic feeds

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Technological innovations & advanced membrane/filter designs

Advancements in membrane and filter design are enabling high-capacity, virus-retentive, and sterile filtration. Automated skids and larger membrane areas support continuous operation at an industrial scale. These innovations are essential for complex biologics, vaccines, and emerging therapies.

Restraint: High cost of advanced filtration consumables and technologies

Premium membranes, single-use capsules, and validated filtration systems are expensive, and these high upfront and operational costs can limit adoption for smaller manufacturers. Cost sensitivity may slow the overall uptake of advanced filtration technologies.

Opportunity: High cost of advanced filtration consumables and technologies

The integration of sensors, real-time monitoring, and automated systems improves process control. Smart filtration workflows enhance reproducibility, reduce human error, and lower downtime. The growing demand for digitalized and automated manufacturing creates opportunities for suppliers of consumables.

Challenge: Membrane fouling and unpredictability with complex biologic feeds

Unpredictable filter performance increases operational risk and reduces efficiency. Frequent monitoring or filter replacement adds complexity and cost at the commercial scale.

PHARMACEUTICAL FILTRATION CONSUMABLES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Sartoclear DL-series depth filter cassettes and modules for cell culture harvest clarification and prefiltration before sterile filtration in biologics and vaccine plants.? Enables high-throughput clarification with fewer change-outs and more consistent product purity at commercial scale.?
Viresolve Pro virus filters for downstream viral clearance of monoclonal antibodies and recombinant proteins.? Increases viral safety and process robustness while supporting scalable, platformable bioprocessing.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem of the pharmaceutical filtration consumables market is closely connected with membrane and media. Based on the different roles that exist within the supply chain, the participating companies are manufacturers, single-use component suppliers, system integrators, biopharmaceutical manufacturers, CMOs/CDMOs, distributors, and end users. Consumable suppliers offer high-capacity sterilizing-grade membrane filters, virus-retentive cartridges, depth filters, microfiltration, ultrafiltration media, and pre-assembled single-use capsules designed to meet commercial-scale throughput and regulatory demands. Biomanufacturers and CMOs rely on various consumables throughout the entire production process, from large-scale upstream clarification to downstream purification and final fill. Sterilization operations are essential for maintaining product quality and achieving global GMP compliance. This process is supported by partners involved in deployment, integration, and engineering, who provide validation, automation compatibility, manifold assembly design, and guidance for scaling up consumable-based workflows. Additionally, distributors and logistics partners ensure a continuous supply of critical filters, capsules, and assemblies to major production facilities worldwide. This tightly coordinated ecosystem enables contamination-controlled and high-efficiency manufacturing of biologics and vaccines while also supporting the industrial-scale production of advanced therapies.

pharmaceutical-filtration-consumables-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

pharmaceutical-filtration-consumables-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Pharmaceutical Filtration Consumables Market, By Type

In 2024, the filters segment accounted for the largest share of the pharmaceutical filtration consumables market, driven by the continuous need for cartridges, capsules, single-use assemblies, and depth media that are routinely replaced during large-batch biologics and vaccine production.

Pharmaceutical Filtration Consumables Market, By Technique

In 2024, microfiltration was the leading technique for consumables such as membrane cartridges and capsules because it efficiently removes bacteria and particulates from large-volume bioreactor harvests and buffer streams, protecting the sterility of injectable and other high-value formulations at the commercial scale.

Pharmaceutical Filtration Consumables Market, By Sterility Type

In 2024, sterile filtration consumables, including validated sterilizing-grade cartridges, capsules, and syringe filters, accounted for the largest share, as biologics and parenteral drugs require robust microbial removal before filling to ensure patient safety and regulatory compliance.

Pharmaceutical Filtration Consumables Market, By Application

In 2024, final product processing was the dominant application segment because filtration at this stage is essential for achieving the required clarity and sterility of commercial drug products, making consumables used here critical for batch release and product quality in large manufacturing facilities.

Pharmaceutical Filtration Consumables Market, By End User

In 2024, pharmaceutical & biopharmaceutical companies represented the leading end-user segment in the pharmaceutical filtration consumables market, as their extensive commercial biologics and vaccine production drives the highest, recurring demand for depth, sterile, and virus-retentive filters.

REGION

Asia Pacific to be fastest-growing region in market during forecast period

In 2024, the Asia Pacific region was recognized as a rapidly developing market for pharmaceutical filtration consumables, as countries like China, India, South Korea, and Singapore increased their capacity for biologics and vaccine production. This growth was driven by strong pipelines in biosimilars and innovative biologics, accompanied by significant investments in regional CDMOs and large in-house biomanufacturing facilities. The primary factors behind the heightened use of high-performance cartridges, capsules, depth modules, and virus-retentive filters were the establishment of new large-scale production facilities.

pharmaceutical-filtration-consumables-market Region

PHARMACEUTICAL FILTRATION CONSUMABLES MARKET: COMPANY EVALUATION MATRIX

In the pharmaceutical filtration consumables market matrix, Merck KGaA (Star Player) holds a leading position with an extensive portfolio of high-efficiency filters for sterile and non-sterile applications, a global reach, and robust support across manufacturing and research settings. This leadership has driven widespread adoption among biopharma companies, contract manufacturers, and hospital networks. Eaton Corporation (Emerging Leader) is rapidly gaining traction, owing to its innovative membrane technologies, flexible product design, and expanding presence in precision therapeutic areas. Meanwhile, specialist companies focusing on niche filtration needs and agile manufacturing practices show significant growth potential, with strategic advancements positioning them as future contenders in the leaders’ quadrant.

pharmaceutical-filtration-consumables-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 11.19 Billion
Market Forecast in 2030 (Value) USD 18.03 Billion
Growth Rate CAGR of 8.5% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Type:
    • Filters
    • Other consumables
  • By Technique:
    • Microfiltration
    • Ultrafiltration
    • Nanofiltration
    • Other Techniques
  • By Sterility Type:
    • Sterile Filtration
    • Non-sterile Filtration
  • By Application:
    • Final Product Processing
    • Raw Material Filtration
    • Cell Separation
    • Water Purification
    • Air Purification
  • By Scale of Operation:
    • Manufacturing Scale
    • Pilot Scale
    • R&D Scale
  • By End User:
    • Pharmaceutical & Biopharmaceutical Companies
    • CDMOs & CMOs
    • CROs
    • Academic Institutes & Research Institutes
Regions Covered North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

WHAT IS IN IT FOR YOU: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET REPORT CONTENT GUIDE

pharmaceutical-filtration-consumables-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Detailed segmentation of consumable product categories Categorized sterile filters, virus-removal membranes, depth filters, micro/ultrafiltration units, single-use capsules, tubing, and assemblies with application-wise relevance. Helps clients align product strategy with high-demand segments and process-critical consumables.
Usage by CDMOs/CMOs Added process-step level detailing: upstream clarification, harvest filtration, buffer/media prep, downstream polishing, and sterile fill-finish. Enables targeted positioning for high-volume and high-utilization stages of biomanufacturing.

RECENT DEVELOPMENTS

  • May 2025 : Pall Corporation announced a major expansion of its manufacturing-scale filtration portfolio with a new line of high-capacity single-use depth and sterile filters designed specifically for large-volume monoclonal antibody and vaccine production, aimed at improving throughput and reducing changeover time in commercial plants.
  • October 2024 : Asahi Kasei Medical introduced the Planova FG1 and later the Planova S20N next-generation virus removal filters, offering significantly higher flux and robust viral clearance for biologics manufacturing.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
 
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL PHARMACEUTICAL FILTRATION CONSUMABLES MARKET
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022–2025)
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2022–2025)
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 8421)
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 8421)
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
 
 
 
 
5.10
IMPACT OF 2025 US TARIFFS ON PHARMACEUTICAL FILTRATION CONSUMABLES MARKET
 
 
 
 
 
 
 
5.10.2
INTRODUCTION
 
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.10.4
IMPACT ON REGIONS
 
 
 
 
 
 
5.10.4.1
US
 
 
 
 
 
5.10.4.2
EUROPE
 
 
 
 
 
5.10.4.3
APAC
 
 
 
 
5.10.5
IMPACT ON END-USE INDUSTRIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
6.1.1
MICROFILTRATION
 
 
 
 
 
6.1.2
ULTRAFILTRATION
 
 
 
 
 
6.1.3
NANOFILTRATION
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
6.2.1
ELECTROSPUN MICROFIBERS
 
 
 
 
 
6.2.2
PHOTOCATALYTIC FILTRATION
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
6.3.1
CHROMATOGRAPHY
 
 
 
 
 
6.3.1
MICROFLUIDICS
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON PHARMACEUTICAL FILTRATION CONSUMABLES MARKET
 
 
 
 
 
 
 
6.7.1
TOP USE CASES & MARKET POTENTIAL
 
 
 
 
 
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL FILTRATION CONSUMABLES MARKET
 
 
 
 
 
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL FILTRATION CONSUMABLES
 
 
 
7
SUSTAINABILITY & REGULATORY LANDSCAPE
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.2
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
 
 
 
 
 
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
9
PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
FILTERS
 
 
 
 
 
 
9.2.1
MEMBRANE FILTERS, BY TYPE OF MATERIAL
 
 
 
 
 
 
9.2.1.1
PES (POLYETHERSULFONE)
 
 
 
 
 
9.2.1.2
PVDF (POLYVINYLIDENE DIFLUORIDE)
 
 
 
 
 
9.2.1.3
NYLON
 
 
 
 
 
9.2.1.4
PTFE (POLYTETRAFLUOROETHYLENE)
 
 
 
 
 
9.2.1.5
MCE & CA (MIXED CELLULOSE ESTER & CELLULOSE ACETATE)
 
 
 
 
 
9.2.1.6
PCTE (POLYCARBONATE TRACK-ETCHED)
 
 
 
 
 
9.2.1.7
OTHER MATERIALS
 
 
 
 
9.2.2
DEPTH FILTERS, BY MEDIA
 
 
 
 
 
 
9.2.2.1
DIATOMACEOUS EARTH
 
 
 
 
 
9.2.2.2
CELLULOSE
 
 
 
 
 
9.2.2.3
ACTIVATED CARBON
 
 
 
 
 
9.2.2.4
PERLITE
 
 
 
 
 
9.2.2.5
OTHER DEPTH FILTER MEDIA
 
 
 
 
9.2.3
AIR FILTERS
 
 
 
 
 
9.2.4
VIRUS FILTERS
 
 
 
 
 
9.2.5
OTHER FILTERS
 
 
 
 
9.3
OTHER CONSUMABLES
 
 
 
 
 
 
9.3.1
FILTRATION ASSEMBLIES
 
 
 
 
 
 
9.3.1.1
MICROFILTRATION ASSEMBLIES
 
 
 
 
 
9.3.1.2
ULTRAFILTRATION ASSEMBLIES
 
 
 
 
 
9.3.1.3
NANOFILTRATION ASSEMBLIES
 
 
 
 
 
9.3.1.4
OTHER FILTRATION ASSEMBLIES
 
 
 
 
9.3.2
FILTER HOLDERS
 
 
 
 
 
9.3.3
FILTRATION ACCESSORIES
 
 
 
10
PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
10.2
MICROFILTRATION
 
 
 
 
 
10.3
ULTRAFILTRATION
 
 
 
 
 
10.4
NANOFILTRATION
 
 
 
 
 
10.5
OTHER TECHNIQUES
 
 
 
 
 
NOTE 6: OTHER TECHNIQUES INCLUDE REVERSE OSMOSIS, ION EXCHANGE, AND PRE-FILTRATION (COARSE FILTRATION)
 
 
 
 
 
11
PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY STERILITY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
STERILE FILTRATION
 
 
 
 
 
11.3
NON-STERILE FILTRATION
 
 
 
 
12
PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
FINAL PRODUCT PROCESSING
 
 
 
 
 
 
12.2.1
ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION
 
 
 
 
 
12.2.2
PROTEIN PURIFICATION
 
 
 
 
 
12.2.3
VACCINES & ANTIBODY PROCESSING
 
 
 
 
 
12.2.4
FORMULATION & FILLING SOLUTIONS
 
 
 
 
 
12.2.5
VIRAL CLEARANCE
 
 
 
 
12.3
RAW MATERIAL FILTRATION
 
 
 
 
 
 
12.3.1
MEDIA BUFFER FILTRATION
 
 
 
 
 
12.3.2
PRE-FILTRATION
 
 
 
 
 
12.3.3
BIOBURDEN TESTING
 
 
 
 
12.4
CELL SEPARATION
 
 
 
 
 
12.5
WATER PURIFICATION
 
 
 
 
 
12.6
AIR PURIFICATION
 
 
 
 
13
PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
13.2
PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
 
 
 
 
 
13.3
CDMOS & CMOS
 
 
 
 
 
13.4
CROS AND ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
14
PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
 
14.2.1
US
 
 
 
 
 
14.2.2
CANADA
 
 
 
 
 
14.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
 
 
 
 
14.3
EUROPE
 
 
 
 
 
 
14.3.1
GERMANY
 
 
 
 
 
14.3.2
UK
 
 
 
 
 
14.3.3
FRANCE
 
 
 
 
 
14.3.4
ITALY
 
 
 
 
 
14.3.5
SPAIN
 
 
 
 
 
14.3.6
REST OF EUROPE
 
 
 
 
 
14.3.7
MACROECONOMIC OUTLOOK OF EUROPE
 
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
 
14.4.1
CHINA
 
 
 
 
 
14.4.2
JAPAN
 
 
 
 
 
14.4.3
INDIA
 
 
 
 
 
14.4.4
AUSTRALIA
 
 
 
 
 
14.4.5
SOUTH KOREA
 
 
 
 
 
14.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
14.4.7
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
 
 
 
 
14.5
LATIN AMERICA
 
 
 
 
 
 
14.5.1
BRAZIL
 
 
 
 
 
14.5.2
MEXICO
 
 
 
 
 
14.5.3
REST OF LATIN AMERICA
 
 
 
 
 
14.5.4
MACROECONOMIC OUTLOOK OF LATIN AMERICA
 
 
 
 
14.6
MIDDLE EAST
 
 
 
 
 
 
14.6.1
GCC
 
 
 
 
 
 
14.6.1.1
UAE
 
 
 
 
 
14.6.1.2
SAUDI ARABIA
 
 
 
 
 
14.6.1.3
REST OF GCC
 
 
 
 
14.6.2
REST OF MIDDLE EAST
 
 
 
 
 
14.6.3
MACROECONOMIC OUTLOOK OF THE MIDDLE EAST
 
 
 
 
14.7
AFRICA
 
 
 
 
 
 
14.7.1
MACROECONOMIC OUTLOOK OF AFRICA
 
 
 
15
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
15.1
INTRODUCTION
 
 
 
 
 
15.2
KEY PLAYER STRATEGY/RIGHT TO WIN
 
 
 
 
 
15.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS,
 
 
 
 
 
 
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
 
 
 
 
 
 
 
15.5.1
STARS
 
 
 
 
 
15.5.2
EMERGING LEADERS
 
 
 
 
 
15.5.3
PERVASIVE PLAYERS
 
 
 
 
 
15.5.4
PARTICIPANTS
 
 
 
 
 
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
15.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
15.5.5.2
REGION FOOTPRINT
 
 
 
 
 
15.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
15.5.5.4
TECHNIQUE FOOTPRINT
 
 
 
 
 
15.5.5.5
APPLICATION FOOTPRINT
 
 
 
15.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
 
 
 
 
 
 
 
15.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
15.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
15.6.3
DYNAMIC COMPANIES
 
 
 
 
 
15.6.4
STARTING BLOCKS
 
 
 
 
 
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
 
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
15.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
 
 
 
15.7
COMPETITIVE SCENARIO
 
 
 
 
 
 
15.7.1
PRODUCT LAUNCHES
 
 
 
 
 
15.7.2
DEALS
 
 
 
 
 
15.7.3
OTHER DEVELOPMENTS
 
 
 
 
15.8
BRAND/ PRODUCT COMPARISON
 
 
 
 
 
 
15.9
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
16
COMPANY PROFILES
 
 
 
 
 
 
16.1
KEY COMPANIES
 
 
 
 
 
 
16.1.1
MERCK KGAA
 
 
 
 
 
16.1.2
DANAHER CORPORATION
 
 
 
 
 
16.1.3
SARTORIUS AG
 
 
 
 
 
16.1.4
PARKER-HANNIFIN CORPORATION
 
 
 
 
 
16.1.5
EATON CORPORATION PLC
 
 
 
 
 
16.1.6
THERMO FISHER SCIENTIFIC, INC.
 
 
 
 
 
16.1.7
SOLVENTUM
 
 
 
 
 
16.1.8
DONALDSON COMPANY, INC.
 
 
 
 
 
16.1.9
PORVAIR PLC
 
 
 
 
 
16.1.10
ALFA LAVAL CORPORATION AB
 
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
 
17.1
RESEARCH DATA
 
 
 
 
 
 
17.1.1
SECONDARY DATA
 
 
 
 
 
 
17.1.1.1
KEY SOURCES OF SECONDARY DATA
 
 
 
 
 
17.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
 
 
 
 
17.1.2
PRIMARY DATA
 
 
 
 
 
 
17.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
17.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
 
 
 
17.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
17.2.1
GLOBAL MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION
 
 
 
 
 
 
17.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
 
 
 
 
 
17.2.1.2
MNM REPOSITORY ANALYSIS
 
 
 
 
 
17.2.1.3
SECONDARY ANALYSIS
 
 
 
 
 
17.2.1.4
PRIMARY RESEARCH
 
 
 
 
 
 
17.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
 
 
17.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
17.4
DATA TRIANGULATION
 
 
 
 
 
17.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
17.7
RESEARCH LIMITATIONS & RISK ASSESSMENT
 
 
 
 
18
APPENDIX
 
 
 
 
 
 
18.1
DISCUSSION GUIDE
 
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
18.4
RELATED REPORTS
 
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 
 
Request for detailed methodology, assumptions & how numbers were triangulated.
Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Filtration Consumables Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Pharmaceutical Filtration Consumables Market

DMCA.com Protection Status